Dow Down0.18% Nasdaq Up0.39%

More On BLT.AX

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials


Benitec Biopharma Limited (BLT.AX)

-ASX
1.11 Down 0.06(5.13%) 2:10AM EDT
ProfileGet Profile for:
Benitec Biopharma Limited
F6A/1-15 Barr Street
Balmain
Sydney, NSW 2041
Australia - Map
Phone: 61 2 9555 6986
Fax: 61 2 9818 2238
Website: http://www.benitec.com

Details 
Index Membership:N/A
Sector:Healthcare
Industry:Drugs - Generic
Full Time Employees:13

Business Summary 

Benitec Biopharma Limited, a biotechnology company, develops novel treatments for chronic and life-threatening conditions based on its gene silencing technology, DNA-directed RNA interference (ddRNAi). The company’s ddRNAi technology provides novel therapeutics to treat a range of human medical diseases and conditions, such as hepatitis C, hepatitis B, wet age-related macular degeneration, cancer-associated pain, drug resistant lung cancer, and oculopharyngeal muscular dystrophy (OPMD). Its pipeline of in-house and partnered therapeutic programs include TT-034 for hepatitis C; Tribetarna for the treatment of chemotherapy resistant non-small cell lung cancer; Hepbarna for Hepatitis B; and Pabparna for the treatment of OPMD. The company also licenses its ddRNAi technology to biopharmaceutical companies for the clinical applications comprising HIV/AIDS, retinitis pigmentosa, and Huntington’s disease. Benitec Biopharma Limited was founded in 1997 and is based in Sydney, Australia.

Key Statistics


Company Websites 
Home Page
Search Yahoo! for:
More on Benitec Biopharma Limited

Key Executives 
 PayExercised
Dr. Peter French B.Sc, M.Sc, Ph.D., MBA,
Chief Exec. Officer, Managing Director and Director
467.00KN/A
Mr. Gregory West CA,
Chief Financial Officer and Company Sec.
285.00KN/A
Dr. Michael Graham ,
Chief Scientific Officer
242.00KN/A
Dr. David A. Suhy Ph.D.,
Sr. VP of R&D
305.00KN/A
Mr. Carl S. Stubbings ,
Chief Bus. Officer
319.00KN/A
Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in AUD.